XTX Topco Ltd Acquires Shares of 41,040 Kenvue Inc. (NYSE:KVUE)

XTX Topco Ltd acquired a new stake in Kenvue Inc. (NYSE:KVUE) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 41,040 shares of the company’s stock, valued at approximately $746,000.

Several other institutional investors and hedge funds have also modified their holdings of the business. Palouse Capital Management Inc. grew its stake in shares of Kenvue by 75.3% in the second quarter. Palouse Capital Management Inc. now owns 149,144 shares of the company’s stock valued at $2,711,000 after acquiring an additional 64,076 shares in the last quarter. Elo Mutual Pension Insurance Co grew its stake in shares of Kenvue by 13.0% in the second quarter. Elo Mutual Pension Insurance Co now owns 161,275 shares of the company’s stock valued at $2,932,000 after acquiring an additional 18,498 shares in the last quarter. Mondrian Investment Partners LTD grew its stake in shares of Kenvue by 20.8% in the second quarter. Mondrian Investment Partners LTD now owns 6,733,023 shares of the company’s stock valued at $124,494,000 after acquiring an additional 1,159,034 shares in the last quarter. Amalgamated Bank grew its stake in shares of Kenvue by 6.2% in the second quarter. Amalgamated Bank now owns 386,739 shares of the company’s stock valued at $7,031,000 after acquiring an additional 22,605 shares in the last quarter. Finally, Tredje AP fonden grew its stake in shares of Kenvue by 152.2% in the second quarter. Tredje AP fonden now owns 194,553 shares of the company’s stock valued at $3,537,000 after acquiring an additional 117,400 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts recently commented on the stock. JPMorgan Chase & Co. upped their price target on shares of Kenvue from $22.00 to $24.00 and gave the company an “overweight” rating in a research note on Wednesday, August 7th. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Kenvue from $23.00 to $24.00 and gave the stock a “buy” rating in a research report on Wednesday, August 7th. Citigroup cut their price objective on shares of Kenvue from $21.00 to $20.00 and set a “neutral” rating for the company in a research report on Wednesday, July 10th. UBS Group upped their price objective on shares of Kenvue from $20.00 to $22.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 7th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $24.00 price objective on shares of Kenvue in a research report on Wednesday, August 7th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $21.44.

Kenvue Stock Up 0.5 %

KVUE stock opened at $23.02 on Monday. The stock has a market capitalization of $44.08 billion, a P/E ratio of 29.51, a price-to-earnings-growth ratio of 2.92 and a beta of 1.40. The company has a current ratio of 0.99, a quick ratio of 0.68 and a debt-to-equity ratio of 0.69. Kenvue Inc. has a 12 month low of $17.67 and a 12 month high of $23.55. The firm has a 50-day moving average price of $20.92 and a 200-day moving average price of $19.96.

Kenvue (NYSE:KVUE) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.28 by $0.04. The business had revenue of $4 billion during the quarter, compared to analyst estimates of $3.93 billion. Kenvue had a net margin of 7.23% and a return on equity of 21.80%. The firm’s quarterly revenue was down .3% on a year-over-year basis. During the same quarter last year, the business earned $0.32 EPS. As a group, equities research analysts anticipate that Kenvue Inc. will post 1.08 EPS for the current fiscal year.

Kenvue Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, August 28th. Investors of record on Wednesday, August 14th were issued a $0.205 dividend. This represents a $0.82 dividend on an annualized basis and a yield of 3.56%. The ex-dividend date of this dividend was Wednesday, August 14th. This is a positive change from Kenvue’s previous quarterly dividend of $0.20. Kenvue’s dividend payout ratio (DPR) is 105.13%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.